← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN AND NAPROXEN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-02-15

Drug application

FDA Application #

ANDA207457

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN AND NAPROXEN SODIUM

Generic name

SUMATRIPTAN AND NAPROXEN SODIUM

Active ingredients

NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2018-02-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown